Recent Popular Leaderboard What is KiKo? Case Reports

IL-17 elicits skin inflammation by acting on different cell types depending on disease context

Need to claim your poster? Find the KiKo table at the conference and they'll help you get set up.

Presented at: Society for Investigative Dermatology 2025

Date: 2025-05-07 00:00:00

Views: 2

Summary: Abstract Body: Therapeutic blockade of IL-17 is highly effective in treating inflammatory skin conditions, but the mechanisms responsible for efficacy are incompletely understood. IL-17 synergizes with PAMPs, DAMPs, and cytokines—especially TNFα—to induce neutrophil chemokine expression and drive tissue inflammation. While keratinocytes have been considered the primary targets of IL-17, we recently showed that subsets of immune-acting fibroblasts in the dermis are also key targets. Here, we evaluated the relative importance of fibroblasts versus keratinocytes in driving type 17 inflammation in skin. Single-cell transcriptomics of healthy human and mouse skin show that keratinocytes and fibroblasts express similarly high levels of IL-17 and TNFα receptors. Functional experiments with primary cultured cells demonstrate that both cell types recognize IL-17 and TNFα but that fibroblasts are induced to express 5-fold more neutrophil chemokine Cxcl1 than keratinocytes (P<0.0001). To evaluate the relative role of each cell type, we developed conditional knockout mice lacking the IL-17 receptor specifically in fibroblasts (Pdgfra△Il17ra) or keratinocytes (Krt14△Il17ra) and exposed these mice to topical or intradermal stimuli. Skin neutrophilia induced by intradermal injection of IL-17 and TNFα was reduced by 80% in Pdgfra△Il17ra mice (P<0.01) but was unchanged in Krt14△Il17ra mice. Conversely, skin neutrophilia after topical imiquimod was reduced by 50% in Pdgfra△Il17ra mice (P<0.01) and by 50% in Krt14△Il17ra mice (P=0.06). Immunostaining showed CXCL1 protein expression by keratinocytes was more abundant in response to topical stimuli (imiquimod, C. albicans) compared to intradermal ones (IL-17/TNFα, S. aureus, C. acnes). Additionally, neutrophil migration to the epidermis was more pronounced with topical stimuli than intradermal ones. Collectively, these findings demonstrate that IL-17 drives skin inflammation through context-dependent cellular targets, with fibroblasts and keratinocytes playing distinct roles based on the depth of inflammatory stimulus. Kellen Cavagnero<sup>1</sup>, Fengwu Li<sup>1</sup>, Carlos Aguilera<sup>1</sup>, Brittany Crown<sup>1</sup>, Richard L. Gallo<sup>1</sup> 1. University of California San Diego, La Jolla, CA, United States. Translational Studies: Preclinical